Improving Organ Donation to Save Thousands of Lives

In 2022, Griffin Catalyst joined with partners to support the Organs Initiative, a coalition leveraging data to drive change with broad bipartisan support. The challenge: To fix a broken, inefficient organ donation system that leads to tens of thousands of healthy organs going unrecovered each year and contributes to 30 Americans dying every day for lack of an available organ. In August 2022, the group achieved the first major overhaul of the organ donation system in 40 years, projected to save over 7,000 lives annually. Almost a year later, in July 2023, Congress unanimously passed legislation to break up the failing national organ monopoly held by the United Network for Organ Sharing (UNOS).
A paramedic delivers an organ for transplant in 2020. In 2023, approximately 103,000 people were on the organ waiting list, and the demand for an efficient, improved organ donation system remains critical to saving thousands of lives.
Photo Credit: serts via Getty

The mismanagement and failures of local organ procurement organizations (OPOs), as well as UNOS — the contractor that manages the national organ transplant system — result in preventable deaths every day. These failures also drive $36 billion per year in Medicare spending for patients on dialysis as they await kidney transplants, representing a full 1% of the entire federal budget. Reforming this system and using data to hold organizations accountable for the first time introduces competition and accountability into an incompetent monopolistic system — and saves lives.

WHO WE’RE SUPPORTING

The Organs Initiative, launched by two nonprofits working together — the Federation of American Scientists and Organize — has driven bipartisan reforms in our national organ donation system. By leveraging data to highlight system failings, increase transparency, and enable the federal government to hold organ contractors accountable for the first time, this work aims to ensure a more effective national system of organ donation on a permanent basis.

In 2022, the group helped to ensure that new data-driven, legally enforceable standards for OPOs went into effect. This critical first step was the capstone to a decades-long fight to hold local organ contractors accountable. Since that time, bipartisan Congressional leaders have escalated investigations into systemic waste, fraud, and abuse among federal organ contractors, as well as called for increased transparency in any effort to ensure evidence of effective organ donation services across the country.

The larger goal of the Organs Initiative is to save lives, replacing the current monopolistic structure with a competitive ecosystem in which the performance incentives for organ contractors are more closely aligned with the interests of patients — and in which failing contractors can be readily replaced by higher performers.

WHY IT MATTERS

According to a bipartisan report from the Senate Finance Committee, “the U.S. transplant network is not working, putting Americans’ lives at risk.” In 2023, approximately 103,000 people were on the organ waiting list. The Washington Post detailed that UNOS uses “out-of-date technology that has crashed for hours at a time” and has also been responsible for the “careless treatment of donated organs [and] organs lost in transit.” The failures of existing federal organ contractors — funded by the American taxpayer — have meant that thousands of Americans die each year waiting for organs.

The Organs Initiative utilizes a proven, data-driven approach to inject competition and accountability into the system of federal organ donation contractors — all with the goal of saving patients’ lives.

WHAT’S THE IMPACT?

The data-driven organ donation policy which went into effect in 2022 is projected to save over 7,000 lives per year and $1 billion per year for the American taxpayer. The legislation unanimously passed in July 2023 lays the groundwork to break up the national organ monopoly which Forbes has described as a “cartel” and will translate to much greater care being provided for generous American donor families and the transplant patients who rely on them. This represents a transformational change in the decades-long fight to hold federal contractors accountable and prevent unnecessary American deaths on the organ waiting list.

A map showing the effectiveness of organ procurement organizations in each state, based on the U.S. Centers for Medicare & Medicaid Services’ three-tiered performance rankings. As of 2021, prior to the enactment of key reforms, the majority of organ procurement organizations nationwide were either underperforming (orange) or failing (red).

Read more from The Washington Post: Congress authorizes overhaul of troubled organ transplant system.

Share

In Brief

November 14, 2023
Griffin Catalyst is supporting a major enhancement of UK Biobank, one of the world’s leading scientific resources for health data and biological samples. Griffin Catalyst’s $10 million gift—matched by Eric Schmidt and Schmidt Futures—will enable UK Biobank and scientists from around the world to accelerate research into disease mechanisms, to better leverage artificial intelligence, and to work towards more personalized options for treatment.
October 30, 2023
Griffin Catalyst is funding the construction and programming of 50 soccer mini-pitches in underserved communities across Florida’s Miami-Dade County. The $5 million initiative, carried out with The Children’s Trust, the U.S. Soccer Foundation, and Miami-Dade County, will increase access to the game for young people county-wide, impacting over 30,000 local children over the next seven years, and help build community in dozens of neighborhoods.
June 30, 2020
Griffin Catalyst has made the largest gift in the history of the Navy SEAL Foundation, to provide critical education, health care, and financial support to members of one of the U.S. military’s most elite special operations forces and their families.
October 28, 2024
Griffin Catalyst provided a seed gift of $2.5 million to accelerate the efforts of Feng Zhang, a faculty member at the Broad Institute of MIT and Harvard, to develop “programmable therapeutics,” an approach that holds promise for revolutionizing medicine by reprogramming cells to cure a wide range of human diseases.
August 30, 2024
Since 2023, Griffin Catalyst has announced transformative gifts to three major health care institutions in Miami. Taken together, the support—totaling $125 million—represents an investment in the future of medical care and research in South Florida.
May 23, 2024
To pay tribute to the nation's most distinguished military heroes—and to unite our country around the values their stories represent—Griffin Catalyst is supporting the National Medal of Honor Museum Foundation with a $30 million gift. The National Medal of Honor Griffin Institute is a key component of a three-pronged, $300 million effort that also includes a new museum in Arlington, Texas, and a new monument in Washington, D.C.
May 20, 2024
In December 2023, Griffin Catalyst and the David Geffen Foundation announced a gift of $400 million to New York's Memorial Sloan Kettering Cancer Center (MSK), one of the most renowned and advanced cancer research and treatment institutions in the world. This landmark gift—the largest donation to the institution in its nearly 150-year history—will allow MSK to significantly expand and upgrade its research, educational, and treatment facilities toward a singular goal: eradicating cancer.
February 12, 2024
The Lincoln Memorial has long been one of America’s most visited monuments and the scene of some of the defining moments of the last century. In time for the 250th anniversary of the country, a new expansion project will transform a massive, long-hidden space beneath the Lincoln Memorial on the National Mall into an immersive museum, exhibition, and theater space, encouraging visitors to explore the story of one of America’s greatest presidents, Abraham Lincoln, and to learn about the nation’s progress toward becoming a more perfect union.
December 20, 2023
On ABC's Good Morning America, Anchors Robin Roberts and Lara Spencer joined with Ken Griffin, Founder and CEO of Citadel and Founder of Griffin Catalyst, and Dr. Selwyn Vickers, President and CEO of Memorial Sloan Kettering (MSK) to announce the largest donation in MSK's nearly 150-year history.